We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.67%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$1.01B
AUM Growth
+$217M
(+27%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
20.87%
Top 10 Holdings %
Top 10 Hldgs %
33.44%
Holding
2,859
New
220
Increased
1,610
Reduced
469
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$57.7M |
| 2 |
Broadcom
AVGO
|
+$13.4M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$10.3M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$9.41M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$1.27M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$1.24M |
| 3 |
AstraZeneca
AZN
|
+$1.1M |
| 4 |
GREK
Global X MSCI Greece ETF
GREK
|
+$1.07M |
| 5 |
HIMU
iShares High Yield Muni Active ETF
HIMU
|
+$779K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Financials | 6.8% |
| 3 | Industrials | 6.1% |
| 4 | Consumer Discretionary | 4.96% |
| 5 | Healthcare | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $7.99K | ﹤0.01% |
166
| – | – |
|
2227
Grayscale Bitcoin Trust
GBTC
$9.76B
| $7.97K | ﹤0.01% |
151
| – | – |
|
2228
Northrim BanCorp
NRIM
$587M
| $7.96K | ﹤0.01% |
348
| – | – |
|
2229
American Financial Group
AFG
$12.1B
| $7.92K | ﹤0.01% |
62
+3
| +5% | +$390 |
|
2230
ADMA Biologics
ADMA
$2.22B
| $7.91K | ﹤0.01% |
878
-971
| -53% | -$15.3K |
|
2231
Mitek Systems
MITK
$834M
| $7.9K | ﹤0.01% |
585
+229
| +64% | +$2.83K |
|
2232
Penumbra
PEN
$12.8B
| $7.88K | ﹤0.01% |
24
+6
| +33% | +$2.03K |
|
|
HDV
2233
iShares Core High Dividend ETF
HDV
$14.8B
| $7.87K | ﹤0.01% |
290
| – | – |
|
2234
Korro Bio
KRRO
$195M
| $7.82K | ﹤0.01% |
+691
| New | +$7.61K |
|
2235
Chord Energy
CHRD
$7.39B
| $7.82K | ﹤0.01% |
55
-19
| -26% | -$2.07K |
|
|
PMT
2236
PennyMac Mortgage Investment
PMT
$842M
| $7.79K | ﹤0.01% |
668
-1,015
| -60% | -$12.5K |
|
|
PRA
2237
DELISTED
ProAssurance
PRA
| $7.79K | ﹤0.01% |
315
+237
| +304% | +$5.78K |
|
|
CTO
2238
CTO Realty Growth
CTO
$815M
| $7.78K | ﹤0.01% |
421
+166
| +65% | +$3.1K |
|
2239
Tredegar Corp
TG
$310M
| $7.78K | ﹤0.01% |
978
| – | – |
|
2240
Appian
APPN
$2.48B
| $7.76K | ﹤0.01% |
322
+246
| +324% | +$6.68K |
|
2241
Arcus Biosciences
RCUS
$3.64B
| $7.73K | ﹤0.01% |
358
| – | – |
|
2242
Arm
ARM
$302B
| $7.71K | ﹤0.01% |
51
| – | – |
|
2243
La-Z-Boy
LZB
$1.69B
| $7.68K | ﹤0.01% |
239
+225
| +1,607% | +$8.13K |
|
2244
Freedom Holding
FRHC
$9.49B
| $7.68K | ﹤0.01% |
53
+46
| +657% | +$5.89K |
|
2245
SK Telecom
SKM
$13.2B
| $7.67K | ﹤0.01% |
+262
| New | +$7.22K |
|
2246
Trupanion
TRUP
$1.18B
| $7.66K | ﹤0.01% |
299
+55
| +23% | +$1.64K |
|
2247
Teleflex
TFX
$5.98B
| $7.66K | ﹤0.01% |
64
-59
| -48% | -$6.5K |
|
|
RAL
2248
Ralliant Corp
RAL
$7.46B
| $7.61K | ﹤0.01% |
183
+121
| +195% | +$5.69K |
|
2249
Universal Display
OLED
$4.19B
| $7.61K | ﹤0.01% |
83
-251
| -75% | -$27.8K |
|
|
CCRN
2250
DELISTED
Cross Country Healthcare
CCRN
| $7.59K | ﹤0.01% |
807
+181
| +29% | +$1.62K |
|
Similar funds
FLAM
AIM
MTCM
CNC
RIM
C
HH
EIA
Versant Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Versant Capital Management held 2,859 positions worth $1.01B, up 27% from $797M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Versant Capital Management deployed $212M of net new capital in Q1 2026, opening 220 new positions and adding to 1,610 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $1.27M trimmed.
- Versant Capital Management's largest Q1 2026 buy was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
- Versant Capital Management added most to Microsoft in Q1 2026, an estimated $57.7M increase.
- Versant Capital Management's biggest Q1 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $1.27M.
- Versant Capital Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.1M.
- Versant Capital Management's ten largest holdings make up 33% of its $1.01B portfolio in Q1 2026.
- Versant Capital Management opened 220 new positions and closed 82 in Q1 2026.
- Versant Capital Management's portfolio value rose 27% quarter-over-quarter to $1.01B.
Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.